These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hepatitis C antibody and transaminase activities in blood donors. Morgan C; Hyland C; Young IF Lancet; 1990 Apr; 335(8694):921. PubMed ID: 1970011 [No Abstract] [Full Text] [Related]
23. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232 [TBL] [Abstract][Full Text] [Related]
24. The epidemiology of non-A, non-B hepatitis in the United States. Alter MJ; Hadler SC; Francis DP; Maynard JE Prog Clin Biol Res; 1985; 182():71-9. PubMed ID: 3929264 [No Abstract] [Full Text] [Related]
25. Infectivity of blood seropositive for hepatitis C virus antibodies. van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden. Schulman S; Wiechel B Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281 [TBL] [Abstract][Full Text] [Related]
27. Type 2 autoimmune hepatitis and hepatitis C virus infection. Vento S; Di Perri G; Luzzati R; Garofano T; Concia E; Bassetti D Lancet; 1990 Apr; 335(8694):921-2. PubMed ID: 1970012 [No Abstract] [Full Text] [Related]
28. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?]. Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598 [No Abstract] [Full Text] [Related]
29. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis C infection in multitransfused patients with acute leukaemia. Murphy MF; Waters AH; Grint PC; Hardiman AE; Lister TA Lancet; 1990 Jan; 335(8680):58-9. PubMed ID: 1967370 [No Abstract] [Full Text] [Related]
31. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Everhart JE; Di Bisceglie AM; Murray LM; Alter HJ; Melpolder JJ; Kuo G; Hoofnagle JH Ann Intern Med; 1990 Apr; 112(7):544-5. PubMed ID: 1690526 [No Abstract] [Full Text] [Related]
32. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Borhany M; Shamsi T; Boota S; Ali H; Tahir N; Naz A; Naseer I; Farzana T; Ansari S; Nadeem M; Zia-Ur-Rahman ; Sangji Z Clin Appl Thromb Hemost; 2011; 17(6):651-5. PubMed ID: 21406412 [TBL] [Abstract][Full Text] [Related]
33. [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U]. Lunel F; Azar N; Fournel JJ; Valla D; Foucault C; Habibi B; Jaulmes D; Perrin M; Opolon P; Huraux JM Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):361-7. PubMed ID: 2177600 [No Abstract] [Full Text] [Related]
34. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease. Sansonno D; Dammacco F Lancet; 1989 Sep; 2(8666):798-9. PubMed ID: 2571030 [No Abstract] [Full Text] [Related]
35. Hepatitis C antibody and chronic liver disease in haemophilia. Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. Chen DS; Kuo GC; Sung JL; Lai MY; Sheu JC; Chen PJ; Yang PM; Hsu HM; Chang MH; Chen CJ J Infect Dis; 1990 Oct; 162(4):817-22. PubMed ID: 2169497 [TBL] [Abstract][Full Text] [Related]
38. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?]. Brandt KH Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949 [No Abstract] [Full Text] [Related]
39. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis]. Renger FG; Raabe A; Forster H; Knot E Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838 [No Abstract] [Full Text] [Related]